Details for New Drug Application (NDA): 209752
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 209752
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Gland Pharma Ltd |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209752
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 209752
Suppliers and Packaging for NDA: 209752
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209752 | ANDA | Walgreens Company | 0363-7131 | 0363-7131-25 | 1 BOTTLE, PLASTIC in 1 CARTON (0363-7131-25) / 2.5 mL in 1 BOTTLE, PLASTIC |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209752 | ANDA | Rugby Laboratories | 0536-1307 | 0536-1307-23 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1307-23) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.2% BASE | ||||
Approval Date: | May 20, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription